The Chennai-based integrated pharma major, Orchid Chemicals & Pharmaceuticals has received the final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules, 5 mg and 10 mg.
With this approval, the total ANDA approval count of Orchid has gone up to 37 while the total ANDA filings stand at 58.